Skip to content

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ranibizumab DFL (ATC-Code nach WHO: S01LA04)

open

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

Read the notice at vergabe-de ↗

Value
unstated
Published
10 Nov 2026
Deadline
31 Dec 2027, 22:58 GMT
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDEG01

Description

Siehe Kurzbeschreibung

Key facts

Reference
165/2026-OH
Procedure
open
Lots
1
Contact
Geschäftsbereich Unternehmenssicherheit, Zentrale Vergabestelle
vergabestelle@plus.aok.de
+49 80010590-80071
Bids opened
31 Dec 2027, 22:59 GMT
Regime
publicSector
  • The documents — every attachment, with its text extracted and searchable
  • Qualification — the notice scored against your company profile
  • Tracking and alerts — a pipeline for your bids, and the matching notices by email
  • Calendar export — the deadline as a calendar file
  • The API and MCP — the same record in your own tools and your AI assistant

Provenance

Source
vergabe-de
Notice id
6ea5562d-5c4d-4934-a8bd-c170c511b76d
OCID
ocds-mnwr74-41661c24-d931-4acb-914e-8e00f722ea18
First seen
12 Nov 2026
Last updated
12 Nov 2026

Licence CC0 1.0 public domain dedication ↗

Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.

View at source ↗GET /api/v1/tenders/a41c22a0-a90e-46a0-94fe-2463b9400697

The source notice is authoritative — verify deadlines and documents there before bidding.